Literature DB >> 8786050

Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa.

M C Kew1.   

Abstract

The carrier rate of hepatitis B virus (HBV) in black Africans averages 10.4% throughout the continent. Even within each country, however, there may be wide variations. HBV carriage in black Africans is largely established in early childhood, mostly through horizontal transmission. Perinatal transmission also occurs but to a much lesser extent than in the Far East. For unknown reasons, HBeAg positivity rates are much lower in black Africans of childbearing age than in women in the Far East. Universal HBV vaccination of infants in South Africa started in April 1995. Effective integration into the Expanded Programme on Vaccination will probably be necessary if administration of second and third doses is to be ensured. Fortunately, a natural process of urbanisation is also having a beneficial effect on the black carrier rate in South Africa, as urban carrier rates tend to be much lower than those in rural area. Within the next 20 years, therefore, there should be a great reduction in the numbers of acute HBV infections and new carriers. However, it will take much longer before there is any substantial impact on the burden of the longterm sequelae of HBV infection--that is, cirrhosis and hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786050      PMCID: PMC1398040          DOI: 10.1136/gut.38.suppl_2.s31

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  High HCV prevalence in Egyptian blood donors.

Authors:  M A Kamel; Y A Ghaffar; M A Wasef; M Wright; L C Clark; F D Miller
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

2.  Protective efficacy of hepatitis B vaccination.

Authors:  M C Kew
Journal:  Lancet       Date:  1995-04-29       Impact factor: 79.321

3.  Incidence of hepatitis C virus in Egyptians.

Authors:  O el-Ahmady; A B Halim; O Mansour; T Salman
Journal:  J Hepatol       Date:  1994-10       Impact factor: 25.083

4.  Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma.

Authors:  M C Kew; M Houghton; Q L Choo; G Kuo
Journal:  Lancet       Date:  1990-04-14       Impact factor: 79.321

5.  Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum.

Authors:  L A Ellis; D Brown; J D Conradie; A Paterson; R Sher; J Millo; E Theodossiadou; G M Dusheiko
Journal:  J Med Virol       Date:  1990-12       Impact factor: 2.327

6.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia.

Authors:  M R Thursz; D Kwiatkowski; C E Allsopp; B M Greenwood; H C Thomas; A V Hill
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

7.  Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma.

Authors:  J Bukh; R H Miller; M C Kew; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Epidemiology of hepatitis B virus infection in South African Chinese.

Authors:  E Song; M C Kew; L Y Hwang; R P Beasley
Journal:  Am J Epidemiol       Date:  1988-10       Impact factor: 4.897

9.  Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity.

Authors:  R Tur-Kaspa; A Klein; S Aharonson
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

10.  Prevalence of hepatitis C virus infection in Africa: anti-HCV antibodies in the general population and in patients suffering from cirrhosis or primary liver cancer.

Authors:  P Coursaget; C Bourdil; R Kastally; B Yvonnet; Z Rampanarivo; J P Chiron; O Bao; I Diop-Mar; J Perrin; F Ntarème
Journal:  Res Virol       Date:  1990 Jul-Aug
View more
  15 in total

1.  Familial pattern of infection with hepatitis B virus among immigrating Ethiopian Jews in Israel.

Authors:  N Bisharat; M Elias; R Raz; E Flatau
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

2.  Hepatitis B Virus Screening and Vaccination in First-generation African Immigrants: A Pilot Study.

Authors:  Olorunseun O Ogunwobi; Omar Dibba; Lin Zhu; Adeodat Ilboudo; Yin Tan; Marilyn A Fraser; Grace X Ma
Journal:  J Community Health       Date:  2019-12

Review 3.  HIV-HBV coinfection among South African patients receiving antiretroviral therapy.

Authors:  Adrian M Di Bisceglie; Mhairi Maskew; Doreen Schulze; Anne Reyneke; Lynne McNamara; Cindy Firnhaber
Journal:  Antivir Ther       Date:  2010

Review 4.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

Review 5.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

6.  Malignant liver tumors in South African children: a national audit.

Authors:  S W Moore; A Davidson; G P Hadley; M Kruger; J Poole; D Stones; L Wainwright; G Wessels
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa.

Authors:  Euphodia Makondo; Trevor G Bell; Anna Kramvis
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia.

Authors:  H Chaouch; W Hachfi; I Fodha; O Kallala; S Saadi; A Bousaadia; F Lazrag; I Bougmiza; M Aouni; A Trabelsi; E Ben Jazia; A Letaief
Journal:  Epidemiol Infect       Date:  2016-08-18       Impact factor: 4.434

9.  Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.

Authors:  Trevor G Bell; Euphodia Makondo; Neil A Martinson; Anna Kramvis
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania.

Authors:  Fabian C Franzeck; Ramadhani Ngwale; Bernadeta Msongole; Marian Hamisi; Omary Abdul; Lars Henning; Emilio Letang; Geoffrey Mwaigomole; Manuel Battegay; Christoph Hatz; Marcel Tanner
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.